We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Heska Corporation | NASDAQ:HSKA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 119.99 | 109.74 | 130.24 | 0 | 01:00:00 |
From May 2019 to May 2024
LOVELAND, Colo., April 13, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to announce its first quarter 2017 financial results in a press release to be issued on Tuesday, May 2, 2017 before the market opens. The Company plans to host a conference call to discuss the results at 9 a.m. MT / 11 a.m. ET on the same day, Tuesday, May 2, 2017.
To access the conference call:
From within the United States, please dial 1-888-256-9157
From outside of the United States, please dial 1-913-312-0860
Reference Conference ID: 8951708
The conference call will be webcast live from the Company's website on www.heska.com.
A telephonic replay of the conference call will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Tuesday, May 9, 2017.
To access the replay:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 8951708
The webcast will also be archived on www.heska.com for 90 days.
About Heska
Heska Corporation (NASDAQ:HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.
|
Heska Corporation: |
Hayden IR: |
|
John McMahon, Chief Financial Officer |
Brett Maas, Managing Partner |
|
970.619.3082 |
646.536.7331 |
|
investorrelations@heska.com |
brett@haydenir.com |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heska-schedules-first-quarter-2017-financial-results-conference-call-for-may-2-2017-300438789.html
SOURCE Heska Corporation
Copyright 2017 PR Newswire
1 Year Heska Chart |
1 Month Heska Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
